PUBLISHER: TechNavio | PRODUCT CODE: 1234287
PUBLISHER: TechNavio | PRODUCT CODE: 1234287
Technavio has been monitoring the bone grafts and substitutes market and is forecast to grow by $1450.51 mn during 2022-2027, accelerating at a CAGR of 8.71% during the forecast period. Our report on the bone grafts and substitutes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing number of orthopedic conditions and surgical cases, increasing demand for dental bone grafts, and rising investment in clinical trials.
Technavio's bone grafts and substitutes market is segmented as below:
By Product
By Application
By Geography
This study identifies the growing adoption of minimally invasive surgeries as one of the prime reasons driving the bone grafts and substitutes market growth during the next few years. Also, emergence of 3D printing in bone grafting and increasing dental tourism in developing countries will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the bone grafts and substitutes market covers the following areas:
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bone grafts and substitutes market vendors that include AlloSource, Arthrex Inc., Baxter International Inc., Bioventus LLC, Geistlich Pharma AG, Integra Lifesciences Holdings Corp., Johnson and Johnson, Medtronic Plc, MTF Biologics, NovaBone Products LLC, Nuvasive Inc., Orthofix Medical Inc., OST Laboratories, RTI Surgical Inc., SeaSpine Holdings Corp., Smith and Nephew plc, Stryker Corp., TBF TISSUE ENGINEERING, Xtant Medical Inc., and Zimmer Biomet Holdings Inc. Also, the bone grafts and substitutes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: